News

Second-line therapies in PBC can change the lives of patients for the better if they provide adequate symptomatic control.

Complement proteins could potentially be used to diagnose PBC, predict risk of PBC and spot patients who may develop serious liver damage.

People living with PBC were found to be significantly more likely to have blood type A compared to people without autoimmune liver disease.

Treatment for primary biliary cholangitis (PBC) needs to be personalized when the first standard medicine does not work well enough.

A group of 151 experts convened to develop a set of recommendations for primary biliary cholangitis (PBC) treatment and care.

Researchers highlight progress in gut-targeted therapies for PBC

Epstein-Barr virus (EBV) infections may be linked to certain autoimmune liver diseases, such as hepatitis and PBC.

Male patients with PBC were more likely than female patients to have advanced disease, yet were less likely to receive care.

New research shows pruritus in PBC significantly increases healthcare visits and costs, highlighting the need for better symptom management.

Most people with primary biliary cholangitis (PBC) can anticipate safe and successful pregnancies, new research finds.